Overview
Shuangbing Xu practices in Wuhan, China. Xu is rated as an Experienced expert by MediFind in the treatment of Urea Cycle Disorders (UCD). Their top areas of expertise are Lung Cancer, Carbamoyl Phosphate Synthetase 1 Deficiency, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
Their clinical research consists of co-authoring 28 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Urea Cycle Disorders (UCD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Carbamoyl Phosphate Synthetase 1 Deficiency
- Lung AdenocarcinomaXu isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerXu isExperienced. Learn about Lung Cancer.
- Nasopharyngeal Carcinoma
- Non-Small Cell Lung Cancer (NSCLC)
- Urea Cycle Disorders (UCD)